Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryl R Peterson

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|September 6, 2003
Transport studies using membrane vesiclesDarryl R Peterson, Richard A Hawkins
American Journal of Therapeutics|March 28, 2014
Blood-brain barrier transport pathways for cytoprotective thiolsDarryl R Peterson, Ernest J Sukowski, Demetrios Zikos
Frontiers in Physiology|December 20, 2021
Editorial: Organization and Functional Properties of the Blood-Brain BarrierDarryl R Peterson, Richard A Hawkins, Juan R Viña
IUBMB Life|December 20, 2002
The complementary membranes forming the blood-brain barrierRichard A Hawkins, Darryl R Peterson, Juan R Viña
American Journal of Therapeutics|April 7, 2015
In Vitro Studies on Degradation of Gamma-L-Glutamyl-L-Cysteine and Gamma-L-Glutamyl-D-Cysteine in Blood: Implications for Treatment of StrokeNsisong Ikpa, Rachel Forman, Kendra Garchow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2004
Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor modelEdward A Neuwelt, Michael A Pagel, Dale F Kraemer, et al.
The American Journal of Pathology|September 7, 2014
Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathyBruce L Riser, Feridoon Najmabadi, Kendra Garchow, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat modelsD Thomas Dickey, Leslie L Muldoon, Nancy D Doolittle, et al.
American Journal of Therapeutics|October 3, 2018
A Glutathione Precursor Reduces Oxidative Injury to Cultured Embryonic CardiomyocytesDarryl R Peterson, Huiya Huang, Dmitriy Peresada, et al.
The American Journal of Pathology|April 11, 2009
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal diseaseBruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|September 6, 2003
Transport studies using membrane vesiclesDarryl R Peterson, Richard A Hawkins
American Journal of Therapeutics|March 28, 2014
Blood-brain barrier transport pathways for cytoprotective thiolsDarryl R Peterson, Ernest J Sukowski, Demetrios Zikos
Frontiers in Physiology|December 20, 2021
Editorial: Organization and Functional Properties of the Blood-Brain BarrierDarryl R Peterson, Richard A Hawkins, Juan R Viña
IUBMB Life|December 20, 2002
The complementary membranes forming the blood-brain barrierRichard A Hawkins, Darryl R Peterson, Juan R Viña
American Journal of Therapeutics|April 7, 2015
In Vitro Studies on Degradation of Gamma-L-Glutamyl-L-Cysteine and Gamma-L-Glutamyl-D-Cysteine in Blood: Implications for Treatment of StrokeNsisong Ikpa, Rachel Forman, Kendra Garchow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2004
Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor modelEdward A Neuwelt, Michael A Pagel, Dale F Kraemer, et al.
The American Journal of Pathology|September 7, 2014
Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathyBruce L Riser, Feridoon Najmabadi, Kendra Garchow, et al.
Cancer Chemotherapy and Pharmacology|October 3, 2007
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat modelsD Thomas Dickey, Leslie L Muldoon, Nancy D Doolittle, et al.
American Journal of Therapeutics|October 3, 2018
A Glutathione Precursor Reduces Oxidative Injury to Cultured Embryonic CardiomyocytesDarryl R Peterson, Huiya Huang, Dmitriy Peresada, et al.
The American Journal of Pathology|April 11, 2009
CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal diseaseBruce L Riser, Feridoon Najmabadi, Bernard Perbal, et al.
Pageof 2